The Laboratory tubes

Product

Good quality L(+)-Tartaric Acid - Spironolactone 52-01-7 Urinary system – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

With this motto in mind, we've come to be one of quite possibly the most technologically innovative, cost-efficient, and price-competitive manufacturers for Posaconazole, DL-Mandelic Acid 90-64-2, L-Carnosine 305-84-0, If you are interested within our products and solutions, you should come to feel absolutely free to ship us your inquiry. We sincerely hope to ascertain win-win company relationships with you.
Good quality L(+)-Tartaric Acid - Spironolactone 52-01-7 Urinary system – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 50kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information:  Not dangerous goods

Spironolactone

Introduction

Spironolactone, is a medication that is primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It is also used in the treatment of high blood pressure, low blood potassium that does not improve with supplementation, early puberty in boys, acne and excessive hair growth in women, and as a part of transgender hormone therapy in transfeminine people.

Specification (USP42)

Item

Specification

Appearance

Light cream-colored to light tan crystalline powder.

Solubility (annual)

Freely soluble in benzene and in chloroform; soluble in ethyl acetate and in alcohol; slightly soluble in methanol and in fiexed oils; practically insoluble in water.

Identification

Infrared Absorption: meets the requirement

HPLC: meets the requirement

Limit of mercapto compounds

≤0.10mL of 0.010N iodine is consumed

Organic impurities

Related compound B ≤0.2%

Related compound A ≤0.2%

Related compound C ≤0.2%

Related compound D ≤0.3%

Epimer ≤0.3%

Related compound I ≤0.1%

Any unspecified impurity ≤0.10%

Total impurities ≤1.0%

Optical rotation -41°~ -45°
Loss on drying ≤0.5%
Residual solvents (In-house) Methanol ≤3000ppm
Tetrahydrofuran ≤720ppm
DMF ≤880ppm
Particle size (In-house) 95% not more than 20 microns

Assay

97.0% ~103.0% on the dried basis


Product detail pictures:

Good quality L(+)-Tartaric Acid - Spironolactone 52-01-7 Urinary system – Neore detail pictures


Related Product Guide:

continue on to further improve, to make sure product top quality in line with market and consumer standard requirements. Our firm has a excellent assurance program have already been established for Good quality L(+)-Tartaric Acid - Spironolactone 52-01-7 Urinary system – Neore , The product will supply to all over the world, such as: Portugal, Madagascar, Sri Lanka, We warmly welcome your patronage and will serve our clients both at home and abroad with products of superior quality and excellent service geared to the trend of further development as always. We believe you will benefit from our professionalism soon.
  • The factory technical staff gave us a lot of good advice in the cooperation process, this is very good, we are very grateful.
    5 Stars By Cindy from Plymouth - 2017.09.30 16:36
    We have been looking for a professional and responsible supplier, and now we find it.
    5 Stars By Paula from Kuala Lumpur - 2018.12.10 19:03